{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T08:07:10Z","timestamp":1790842030355,"version":"4.1.0"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,12]],"date-time":"2024-01-12T00:00:00Z","timestamp":1705017600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000050","name":"National Heart Lung and Blood Institute","doi-asserted-by":"publisher","award":["T32 HL134616"],"award-info":[{"award-number":["T32 HL134616"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["R01 NS124681"],"award-info":[{"award-number":["R01 NS124681"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","award":["P50 AR065139"],"award-info":[{"award-number":["P50 AR065139"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006928","name":"The Ohio State University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006928","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","nmd-journal.com","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuromuscular Disorders"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.nmd.2024.01.004","type":"journal-article","created":{"date-parts":[[2024,1,12]],"date-time":"2024-01-12T04:17:21Z","timestamp":1705033041000},"page":"1-5","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Gene therapy delivered micro-dystrophins co-localize with transgenic utrophin in dystrophic skeletal muscle fibers"],"prefix":"10.1016","volume":"36","author":[{"given":"Swathy","family":"Krishna","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arden B.","family":"Piepho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dana M.","family":"Lake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurel R.","family":"Cumby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaelyn K.","family":"Lortz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeovanna","family":"Lowe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey S.","family":"Chamberlain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3239-8530","authenticated-orcid":false,"given":"Jill A.","family":"Rafael-Fortney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nmd.2024.01.004_bib0001","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1002\/ana.23528","article-title":"Evidence-based path to newborn screening for Duchenne muscular dystrophy","volume":"71","author":"Mendell","year":"2012","journal-title":"Ann Neurol"},{"key":"10.1016\/j.nmd.2024.01.004_bib0002","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/s41572-021-00248-3","article-title":"Duchenne muscular dystrophy","volume":"7","author":"Duan","year":"2021","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.nmd.2024.01.004_bib0003","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/nm0302-253","article-title":"Modular flexibility of dystrophin: implications for gene therapy of Duchenne muscular dystrophy","volume":"8","author":"Harper","year":"2002","journal-title":"Nat Med"},{"key":"10.1016\/j.nmd.2024.01.004_bib0004","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.ymthe.2019.01.002","article-title":"Development of novel micro-dystrophins with enhanced functionality","volume":"27","author":"Ramos","year":"2019","journal-title":"Mol Ther"},{"key":"10.1016\/j.nmd.2024.01.004_bib0005","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1080\/14737175.2023.2249607","article-title":"Gene therapy for Duchenne muscular dystrophy: an update on the latest clinical developments","volume":"23","author":"Happi Mbakam","year":"2023","journal-title":"Expert Rev Neurother"},{"key":"10.1016\/j.nmd.2024.01.004_bib0006","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1089\/hum.2023.29242.ddu","article-title":"Duchenne muscular dystrophy gene therapy in 2023: status, perspective, and beyond","volume":"34","author":"Duan","year":"2023","journal-title":"Hum Gene Ther"},{"key":"10.1016\/j.nmd.2024.01.004_bib0007","unstructured":"US Food and Drug Administration. ELEVIDYS\u2122 Highlights of prescribing information. 2023."},{"key":"10.1016\/j.nmd.2024.01.004_bib0008","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1002\/mus.27955","article-title":"Long-term safety and functional outcomes of delandistrogene moxeparvovec gene therapy in patients with Duchenne muscular dystrophy: a phase 1\/2a nonrandomized trial","volume":"69","author":"Mendell","year":"2024","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.nmd.2024.01.004_bib0009","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1093\/hmg\/ddl083","article-title":"Naturally occurring utrophin correlates with disease severity in Duchenne muscular dystrophy","volume":"15","author":"Kleopa","year":"2006","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.nmd.2024.01.004_bib0010","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1093\/hmg\/ddz049","article-title":"The potential of utrophin and dystrophin combination therapies for Duchenne muscular dystrophy","volume":"28","author":"Guiraud","year":"2019","journal-title":"Hum Mol Gen"},{"key":"10.1016\/j.nmd.2024.01.004_bib0011","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/S0092-8674(00)80532-2","article-title":"Utrophin-dystrophin-deficient mice as a model for Duchenne muscular dystrophy","volume":"90","author":"Deconinck","year":"1997","journal-title":"Cell"},{"key":"10.1016\/j.nmd.2024.01.004_bib0012","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1038\/4033","article-title":"Expression of full-length utrophin prevents muscular dystrophy in mdx mice","volume":"4","author":"Tinsley","year":"1988","journal-title":"Nat Med"},{"key":"10.1016\/j.nmd.2024.01.004_bib0013","doi-asserted-by":"crossref","first-page":"e146511","DOI":"10.1172\/jci.insight.146511","article-title":"Micro-dystrophin gene therapy prevents heart failure in an improved Duchenne muscular dystrophy cardiomyopathy mouse model","volume":"6","author":"Howard","year":"2021","journal-title":"JCI Insight"},{"key":"10.1016\/j.nmd.2024.01.004_bib0014","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.omtm.2023.02.001","article-title":"Micro-dystrophin gene therapy demonstrates long-term cardiac efficacy in a severe Duchenne muscular dystrophy model","volume":"28","author":"Piepho","year":"2023","journal-title":"Mol Ther Methods Clin Dev"},{"key":"10.1016\/j.nmd.2024.01.004_bib0015","doi-asserted-by":"crossref","first-page":"R102","DOI":"10.1093\/hmg\/ddz128","article-title":"AAV-based gene therapies for the muscular dystrophies","volume":"28","author":"Crudele","year":"2019","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.nmd.2024.01.004_bib0016","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1000958","article-title":"The polyproline site in hinge 2 influences the functional capacity of truncated dystrophins","volume":"6","author":"Banks","year":"2010","journal-title":"PLoS Genet"},{"key":"10.1016\/j.nmd.2024.01.004_bib0017","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1172\/JCI36612","article-title":"Dystrophins carrying spectrin-like repeats 16 and 17 anchor nNOS to the sarcolemma and enhance exercise performance in a mouse model of muscular dystrophy","volume":"119","author":"Lai","year":"2009","journal-title":"J Clin Invest"},{"key":"10.1016\/j.nmd.2024.01.004_bib0018","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1152\/physrev.2001.81.1.209","article-title":"Physiology of nitric oxide in skeletal muscle","volume":"81","author":"Stamler","year":"2001","journal-title":"Physiol Rev"},{"key":"10.1016\/j.nmd.2024.01.004_bib0019","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1083\/jcb.134.1.93","article-title":"Forced expression of dystrophin deletion constructs reveals structure-function correlations","volume":"134","author":"Rafael","year":"1996","journal-title":"J Cell Biol"},{"key":"10.1016\/j.nmd.2024.01.004_bib0020","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/S0960-8966(02)00286-9","article-title":"Cardiomyopathic features associated with muscular dystrophy are independent of dystrophin absence in cardiovasculature","volume":"13","author":"Hainsey","year":"2003","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.nmd.2024.01.004_bib0021","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/ng0598-79","article-title":"Skeletal muscle-specific expression of a utrophin transgene rescues utrophin-dystrophin deficient mice","volume":"19","author":"Rafael","year":"1998","journal-title":"Nat Genet"},{"key":"10.1016\/j.nmd.2024.01.004_bib0022","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/j.fmre.2022.07.004","article-title":"Promising therapeutic approaches of utrophin replacing dystrophin in the treatment of Duchenne muscular dystrophy","volume":"2","author":"Wu","year":"2022","journal-title":"Fundamental Research"},{"key":"10.1016\/j.nmd.2024.01.004_bib0023","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1038\/360588a0","article-title":"Association of dystrophin-related protein with dystrophin-associated proteins in mdx muscle","volume":"360","author":"Matsumura","year":"1992","journal-title":"Nature"},{"key":"10.1016\/j.nmd.2024.01.004_bib0024","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.1093\/hmg\/ddy113","article-title":"Variable rescue of microtubule and physiological phenotypes in mdx muscle expressing different miniaturized dystrophins","volume":"27","author":"Nelson","year":"2018","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.nmd.2024.01.004_bib0025","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1073\/pnas.1211431109","article-title":"\u03b12 and \u03b13 helices of dystrophin R16 and R17 frame a microdomain in the alpha1 helix of dystrophin R17 for neuronal NOS binding","volume":"110","author":"Lai","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.nmd.2024.01.004_bib0026","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.ymthe.2006.01.007","article-title":"C-terminal-truncated microdystrophin recruits dystrobrevin and syntrophin to the dystrophin-associated glycoprotein complex and reduces muscular dystrophy in symptomatic utrophin\/dystrophin double-knockout mice","volume":"14","author":"Yue","year":"2006","journal-title":"Mol Ther"},{"key":"10.1016\/j.nmd.2024.01.004_bib0027","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1242\/jcs.064808","article-title":"Sarcolemmal nNOS anchoring reveals a qualitative difference between dystrophin and utrophin","volume":"123","author":"Li","year":"2010","journal-title":"J Cell Sci"}],"container-title":["Neuromuscular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960896624000233?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960896624000233?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,16]],"date-time":"2024-11-16T19:33:31Z","timestamp":1731785611000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960896624000233"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":27,"alternative-id":["S0960896624000233"],"URL":"https:\/\/doi.org\/10.1016\/j.nmd.2024.01.004","relation":{},"ISSN":["0960-8966"],"issn-type":[{"value":"0960-8966","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Gene therapy delivered micro-dystrophins co-localize with transgenic utrophin in dystrophic skeletal muscle fibers","name":"articletitle","label":"Article Title"},{"value":"Neuromuscular Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nmd.2024.01.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}